Overview

NAD Supplementation and Vascular Health in PAD

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
This pilot open-label clinical trial was designed to investigate whether 4-week supplementation with 1g daily NR impacts endothelial function in peripheral circulation, cerebrovascular hemodynamics, cognitive function in older adults with peripheral artery disease.
Phase:
PHASE1
Details
Lead Sponsor:
University of Oklahoma
Treatments:
nicotinamide-beta-riboside